Allergy Immunotherapy Market Size

  • Report ID: 3769
  • Published Date: Oct 09, 2024
  • Report Format: PDF, PPT

Allergy Immunotherapy Market Size

Allergy Immunotherapy Market size was over USD 1.85 billion in 2024 and is likely to reach USD 5.81 billion by the end of 2037, witnessing around 9.2% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of allergy immunotherapy is assessed at USD 1.99 billion.

Because more people are developing these allergies, the market is expanding. The healthcare system is challenged by complex allergies, which cause people's health to deteriorate too much. Asthma and other allergies that affect the body's respiratory system are on the rise as a result of the environment's increasing air pollution. As per a recent report, asthma was the primary diagnosis in 38,792 hospitalizations between 2017 and 2018. Also, Asthma-related fatalities totaled 417 in 2020.

Furthermore, a rising number of immunotherapy treatments are under development to treat patients' allergies. This element is anticipated to fuel market expansion. Sublingual immunotherapy has been investigated by certain researchers for a variety of food allergies, including those to milk, peanuts, kiwis, and peaches. Numerous studies have shown that therapy cannot be effective without consistent pharmaceutical use.


Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 3769
  • Published Date: Oct 09, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of allergy immunotherapy is assessed at USD 1.99 billion.

The allergy immunotherapy market size was over USD 1.85 billion in 2024 and is likely to reach USD 5.81 billion by the end of 2037, witnessing around 9.2% CAGR during the forecast period i.e., between 2025-2037. Growing research and development activities and growing prevalence of allergies will boost the market growth.

Asia Pacific industry is anticipated to hold largest revenue share 36% by 2037, due to rising presence of major key players in the region.

The major players in the market are ALK, Stallergenes Greer, Mylan N.V., HAL Allergy B.V., LETIPharma, AstraZeneca, Takeda Pharmaceuticals Company Ltd, Chugai Pharmaceutical Co., Ltd, Eisai Co. Ltd, Astellas Pharma Inc. and others.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample